Oncology Institute (TOI) Cash from Operations (2020 - 2025)
Oncology Institute's Cash from Operations history spans 6 years, with the latest figure at 3233000.0 for Q4 2025.
- For Q4 2025, Cash from Operations fell 19.17% year-over-year to 3233000.0; the TTM value through Dec 2025 reached 24587000.0, up 8.0%, while the annual FY2025 figure was 24587000.0, 7.35% up from the prior year.
- Cash from Operations reached 3233000.0 in Q4 2025 per TOI's latest filing, up from 12630000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 4000000.0 in Q4 2024 to a low of 23335000.0 in Q4 2021.
- Average Cash from Operations over 5 years is 9103100.0, with a median of 9431000.0 recorded in 2023.
- Peak YoY movement for Cash from Operations: crashed 3759.7% in 2022, then skyrocketed 202.75% in 2024.
- A 5-year view of Cash from Operations shows it stood at 23335000.0 in 2021, then surged by 40.02% to 13997000.0 in 2022, then soared by 72.19% to 3893000.0 in 2023, then surged by 202.75% to 4000000.0 in 2024, then decreased by 19.18% to 3233000.0 in 2025.
- Per Business Quant, the three most recent readings for TOI's Cash from Operations are 3233000.0 (Q4 2025), 12630000.0 (Q3 2025), and 10202000.0 (Q2 2025).